Geneva, Switzerland – In a significant stride towards global health equity and human rights, the International Bureau for Epilepsy (IBE) officially unveiled its groundbreaking Policy Advocacy Report at the 79th World Health Assembly in Geneva. This pivotal document marks a concerted effort to weave the authentic voices, pressing priorities, and lived experiences of individuals battling epilepsy directly into the fabric of international policy discussions, demanding a re-evaluation of how societies address this complex neurological condition.
n
The launch, a cornerstone event at the highest echelons of global health governance, underscores a growing recognition that epilepsy extends far beyond a mere medical diagnosis. It encompasses a spectrum of human rights, social inclusion challenges, and significant barriers to sustainable development, impacting millions worldwide. The IBE’s report, meticulously informed by the findings of its landmark Global Epilepsy Needs Study (GENS), serves as an essential bridge, translating raw, real-world insights and comprehensive global evidence into a set of practical, actionable recommendations. These recommendations are meticulously crafted to invigorate and strengthen the implementation of the World Health Organization’s (WHO) Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders (IGAP) 2022–2031, transforming global commitments into tangible improvements for individuals living with epilepsy.
n
Chronology of a Pivotal Launch and Collaborative Spirit
n
The unveiling of this seminal report was not merely an announcement but a carefully orchestrated high-level side event held at the prestigious WHO Headquarters. This event, a testament to collaborative spirit and shared vision, was co-organised by One Neurology – a powerful alliance dedicated to advancing neurological health – and a consortium of WHO Non-State Actors. This crucial group included the IBE itself, alongside the Multiple Sclerosis International Federation (MSIF) and Alzheimer’s Disease International (ADI), signifying a unified front in advocating for the rights and needs of people living with diverse neurological conditions. The generous and vital support of the Italian Ministry of Health further solidified the international backing and political will behind this initiative, highlighting the importance of governmental engagement in translating advocacy into action.
n
Speaking with conviction and clarity during the event, Donna Walsh, CEO of the IBE, articulated the profound urgency of ensuring that global frameworks are not simply theoretical constructs but translate into meaningful, measurable improvements in the everyday lives of people with epilepsy. "There is no point creating global frameworks unless they really address what matters most to those people living with neurological conditions across the world," Ms. Walsh emphatically stated, cutting to the core of the policy-practice disconnect. She elaborated on the foundational philosophy behind the GENS study, explaining its ambitious aim to look "beyond seizures alone." This broader perspective sought to cultivate a deeper, more nuanced understanding of the multifaceted realities and daily challenges confronting people with epilepsy across diverse cultural, social, and economic landscapes worldwide.
n
The journey from initial concept to a globally recognized policy document involved extensive groundwork. The GENS study itself represents an unprecedented effort to capture the lived experience, meticulously gathering nearly 5,300 survey responses and conducting 75 in-depth interviews across a multitude of countries. This comprehensive data collection delved into critical areas impacting daily life, including healthcare access and quality, educational opportunities, employment prospects, transportation accessibility, personal safety, and the broader context of social inclusion. The sheer scale and depth of this qualitative and quantitative research provide the report with an unparalleled evidence base, ensuring its recommendations are rooted in the authentic experiences of the community it serves.
n
The Global Epilepsy Needs Study (GENS): A Foundation of Lived Experience and Unveiled Realities
n
The Global Epilepsy Needs Study (GENS) stands as the bedrock of the IBE’s Policy Advocacy Report, providing an unparalleled snapshot of the challenges and disparities faced by individuals with epilepsy globally. Its extensive methodology, encompassing thousands of surveys and dozens of in-depth interviews, moved beyond clinical assessments to capture the human dimensions of living with epilepsy. This approach was critical to understanding how the condition permeates every facet of life, from the personal to the societal.
n
The study’s scope was intentionally broad, exploring areas often overlooked in purely medical assessments:
n
- n
- Healthcare: Beyond the availability of anti-seizure medications, GENS investigated access to specialist neurologists, timely and accurate diagnosis, affordability of treatment, continuity of care, and the integration of epilepsy services within primary healthcare systems. Findings likely revealed significant disparities between high-income and low-income settings, and between urban and rural areas, impacting adherence to treatment and overall health outcomes. The study would have illuminated instances where stigma acts as a barrier to seeking medical help, exacerbating untreated cases and preventable complications.
- Education: GENS explored the profound impact of epilepsy on educational attainment. This included examining barriers to school attendance, lack of understanding and support from teachers and school administrations, bullying and social isolation experienced by students with epilepsy, and the absence of tailored educational resources or accommodations. The data likely highlighted how seizures, medication side effects, and stigma can lead to interrupted schooling, lower academic achievement, and ultimately, reduced life opportunities.
- Employment: The study delved into the significant challenges individuals with epilepsy face in the workplace. This encompassed issues such as discrimination during hiring processes, lack of reasonable accommodations (e.g., flexible hours, designated safe spaces), misconceptions among employers and colleagues, and the fear of job loss due to seizures. GENS findings would have underscored how unemployment or underemployment among people with epilepsy contributes to economic hardship, reduced independence, and diminished self-esteem, perpetuating a cycle of disadvantage.
- Transportation: GENS investigated the practical difficulties related to mobility and independence. Restrictions on driving licenses in many countries, coupled with inadequate public transportation options or safety concerns during seizures in public spaces, significantly limit the autonomy of people with epilepsy. The study likely highlighted how these limitations can hinder access to education, employment, healthcare, and social activities, reinforcing isolation.
- Safety: The report explored safety concerns extending beyond the immediate risk of injury during a seizure. This included public perception and fear, lack of basic seizure first aid knowledge among the general population, and the vulnerability of individuals with epilepsy in certain environments. The study would have revealed instances where a lack of understanding leads to inappropriate responses during a seizure, or where fear leads to societal exclusion.
- Social Inclusion: Perhaps one of the most poignant areas of investigation, GENS examined the pervasive impact of stigma, discrimination, and misconceptions on social participation. The study likely captured experiences of social isolation, challenges in forming relationships, impact on mental health (depression, anxiety), and the general feeling of being "othered" or misunderstood. These findings are crucial for repositioning epilepsy not just as a medical condition but as a significant social determinant of health and well-being.
n
n
n
n
n
n
n
The collective insights from GENS powerfully demonstrated that effective epilepsy care cannot be confined to clinical settings alone. It demands a holistic, person-centred approach that addresses the societal, economic, and psychological dimensions of the condition. The study’s meticulous collection of lived experiences provided irrefutable evidence for the need to look "beyond seizures," illuminating the broader realities that shape the lives of millions.
n
Bridging the Chasm: Policy Commitments Versus Everyday Reality
n
One of the most potent and recurrent themes that emerged from the launch event, and indeed from the GENS study itself, was the glaring disparity between global policy commitments and the often harsh, unyielding realities faced by people with neurological conditions on a daily basis. Ms. Walsh’s incisive observation, "There is no point creating global frameworks unless they really address what matters most to those people living with neurological conditions across the world," served as a powerful indictment of policies that fail to translate into tangible, positive change at the grassroots level.
n
This gap manifests in myriad ways. Governments might sign international conventions or endorse WHO action plans, yet lack the political will, financial resources, or integrated strategies to implement these commitments effectively. For instance, a national health plan might theoretically guarantee access to essential medicines, but in practice, these medications may be unavailable in rural areas, prohibitively expensive, or administered by inadequately trained personnel. Similarly, anti-discrimination laws may exist on paper, but societal stigma and lack of enforcement mechanisms continue to marginalize individuals with epilepsy in education, employment, and social settings. The report positions epilepsy not merely as a health issue requiring medical intervention but fundamentally as a human rights issue, a social inclusion imperative, and a critical component of achieving sustainable development goals. Recognizing epilepsy through these lenses necessitates a multi-sectoral response that extends beyond ministries of health to include education, labour, social welfare, and justice departments.
n
The Blueprint for Change: Ten Global Policy Priorities and Recommendations
n
The IBE Policy Advocacy Report is not just a diagnosis of current deficiencies; it is a meticulously crafted blueprint for action. It articulates ten overarching global policy priorities, each accompanied by domain-specific recommendations, designed to guide governments, healthcare providers, and civil society organisations towards a more equitable and supportive future for people with epilepsy. These priorities are:
n
Strengthening Human Rights-Based Frameworks
n
This priority calls for the explicit integration of epilepsy into existing human rights conventions and the development of specific legislation to protect individuals with epilepsy from discrimination. It advocates for legal frameworks that ensure equal opportunities in employment, education, and public life, and for mechanisms that guarantee access to justice and redress for rights violations. The aim is to dismantle systemic barriers and foster environments where people with epilepsy can exercise their full human rights without prejudice.
n
Increasing Awareness of Epilepsy and Seizure First Aid
n
Pervasive myths and misconceptions surrounding epilepsy fuel stigma and fear, often leading to inappropriate responses during a seizure. This priority champions robust public education campaigns to demystify epilepsy, explain its causes, and clarify that it is not contagious. Crucially, it advocates for widespread training in seizure first aid, empowering communities, first responders, educators, and employers to react calmly and effectively during a seizure, potentially preventing injuries and reducing distress.
n
Developing National Epilepsy Plans and Programmes
n
Global frameworks like IGAP provide overarching guidance, but their effectiveness hinges on national and sub-national implementation. This priority stresses the necessity for individual countries to develop tailored national epilepsy plans and programmes. These plans should include clear objectives, dedicated budgets, inter-ministerial collaboration, and mechanisms for monitoring and evaluation, ensuring that global commitments are localised and responsive to specific national contexts and needs.
n
Improving Access to Healthcare and Medicines
Access to timely diagnosis, appropriate treatment, and affordable anti-seizure medications (ASMs) remains a significant challenge globally, particularly in low-resource settings. This priority advocates for strengthening primary healthcare systems to include epilepsy care, increasing the availability and affordability of essential ASMs, expanding the workforce of trained neurologists and epilepsy specialists, and leveraging telemedicine to reach underserved populations.
Providing Integrated Holistic Care
Epilepsy impacts more than just brain function; it affects mental health, social well-being, and overall quality of life. This priority champions an integrated, holistic approach to care that addresses the physical, psychological, and social needs of individuals with epilepsy. This includes access to mental health support, rehabilitation services, social work interventions, and peer support networks, recognizing the interconnectedness of various aspects of health.
Driving Research and Innovation
Advances in understanding epilepsy, developing new treatments, and improving diagnostic tools are crucial for enhancing outcomes. This priority calls for increased investment in epilepsy research, fostering innovation in drug development, non-pharmacological therapies, and diagnostic technologies. It also advocates for facilitating participation in clinical trials and ensuring that research findings are translated into accessible clinical practice.
Creating Epilepsy-Friendly Environments
Societal environments can either facilitate or hinder the participation of people with epilepsy. This priority advocates for the creation of inclusive and safe environments in all aspects of public life. This includes promoting workplace accommodations, ensuring safe and accessible public transportation, designing public spaces with safety considerations in mind, and fostering a culture of understanding and acceptance in schools and communities.
Ensuring Meaningful Lived Experience Involvement
Central to the report’s philosophy is the principle of "nothing about us without us." This priority emphasizes the imperative of meaningfully involving people with epilepsy and their caregivers in all stages of policy and programme development, implementation, and evaluation. Their unique insights are invaluable in ensuring that interventions are relevant, effective, and truly meet the needs of the community.
Supporting Patient Organisations
Patient organisations play an indispensable role in advocacy, providing support networks, disseminating information, and empowering individuals with epilepsy. This priority calls for robust support for these organisations through funding, capacity building, and recognition as essential partners in policy formulation and service delivery. Strengthening these groups amplifies the collective voice of the epilepsy community.
The Intersectoral Global Action Plan (IGAP) and the Report’s Role
The IBE’s Policy Advocacy Report arrives at a critical juncture, directly informing and strengthening the implementation of the World Health Organization’s Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders (IGAP) 2022–2031. IGAP represents a monumental commitment by the WHO and its member states to address the global burden of neurological conditions, including epilepsy, through a comprehensive, cross-sectoral approach. It outlines strategic objectives ranging from strengthening governance and care to promoting research and innovation.
The IBE report serves as a vital companion to IGAP, providing the granular detail and the lived experience perspective that is crucial for effective implementation. While IGAP sets the overarching goals, the IBE report offers practical, evidence-based recommendations on how to achieve those goals specifically for epilepsy. Donna Walsh explicitly underscored this synergy, stating, "We hope that this will be a critical evidence base to inform policymaking and decision-making, particularly when it comes to IGAP implementation globally." This highlights the report’s intended function as a dynamic implementation and advocacy tool, guiding stakeholders in translating IGAP’s broad mandates into concrete, impactful actions that resonate with the real needs of people with epilepsy.
A Roadmap for Global Action: Implications and the Path Forward
The GENS Policy Advocacy Report is more than just a document; it is intended to serve as a comprehensive roadmap for a diverse array of stakeholders committed to improving the lives of people affected by epilepsy worldwide. This includes governments at national and sub-national levels, who are urged to integrate the report’s recommendations into their national health strategies and legislative frameworks. Healthcare and research leaders are called upon to drive innovation, improve service delivery, and invest in epilepsy-specific research. Advocates and civil society organisations are empowered with a robust evidence base to strengthen their campaigns and ensure that the voices of those they represent are heard and acted upon.
The long-term implications of this report are profound. If successfully adopted and implemented, it promises to:
- Reduce the treatment gap: Ensuring more people receive timely diagnosis and effective treatment.
- Combat stigma and discrimination: Fostering more inclusive and understanding societies.
- Improve quality of life: Enabling individuals with epilepsy to participate fully in education, employment, and social life.
- Strengthen health systems: Integrating epilepsy care into broader public health initiatives.
- Advance human rights: Upholding the dignity and autonomy of all individuals, regardless of their neurological status.
The International Bureau for Epilepsy has affirmed its commitment to leveraging the rich data and insights gleaned from GENS to inform its ongoing global advocacy efforts, shape its new strategic plan, and guide its collaborative activities with its extensive network of chapters and partners. Notably, Epilepsy Alliance America has proudly served as an associate chapter of IBE since 2021, embodying the spirit of international collaboration and shared purpose.
In conclusion, the IBE’s Policy Advocacy Report represents a landmark achievement in the global health landscape. By centering the lived experiences of people with epilepsy, it offers an indispensable tool for transforming policy into practice, bridging the gap between global commitments and everyday realities. It is a powerful call to action, demanding collective responsibility and unwavering commitment from all stakeholders to build a world where individuals with epilepsy can live free from stigma, fear, and discrimination, and achieve their full potential. The journey ahead requires sustained effort, but with this report, the path towards comprehensive, equitable, and human rights-based epilepsy care has been illuminated with unprecedented clarity.
